NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full-year 2025. “2025 was a catapult year for Johnson & Johnson, fueled by the strongest portfolio and pipeline in our history,” …
Author: Business Wire
Alcon Completes $750 Million Share Repurchase Program
GENEVA–(BUSINESS WIRE)–Alcon Completes $750 Million Share Repurchase Program
Alcon Completes $750 Million Share Repurchase Program
GENEVA–(BUSINESS WIRE)–Alcon Completes $750 Million Share Repurchase Program
Artificial Iris Market Growth Forecast (2026-2032) Featuring Strategic Profiles of Leading Players Art Eyes, BrightOcular, Ophtec, REPER-NN, Spectrum Surgical, VEO Ophthalmics and More – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Artificial Iris Market – Global Forecast 2026-2032” has been added to ResearchAndMarkets.com’s offering. The Artificial Iris Market has shown significant growth, expanding from USD 17.71 million in 2024 to USD 19.31 millio…
Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2025 financial results on Wednesday,…
Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release fourt…
Emmecell Appoints Ramin Valian as Chief Executive Officer to Advance Magnetic Cell Delivery Platform
MENLO PARK, Calif.–(BUSINESS WIRE)–Emmecell announces the appointment of ophthalmology leader Ramin Valian as CEO.
Chicago Atlantic Provides $16.5 Million Term Loan to Ocular Science, Inc., a Leading Biotech Company Focused on Compounded Ophthalmic Products
CHICAGO–(BUSINESS WIRE)–Chicago Atlantic announced its role as sole arranger and administrative agent in the closing of a $16.5 million senior secured term loan for Ocular Science, Inc. (“Ocular Science”), an affiliate of OSRX, Inc. OSRX is a leading…
STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, and Broadwood Partners, L.P. …
In Editorial, The New England Journal of Medicine Calls Science Corporation's PRIMA Implant "The First Treatment to Restore Vision" In Patients Suffering From Advanced Geographic Atrophy Due to Age-related Macular Degeneration
ALAMEDA, Calif.–(BUSINESS WIRE)–An editorial published today in The New England Journal of Medicine (NEJM) writes that Science Corporation’s PRIMA implant is the first treatment in clinical trials to successfully restore functional vision to certain …
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced its prelimina…
Axol Bioscience Raises $2.8M to Advance US Expansion and Product Development
CAMBRIDGE, England & EDINBURGH, Scotland–(BUSINESS WIRE)–Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£…
Arrow Electronics Supports .lumen in Scaling Production of Its Glasses for the Blind
CENTENNIAL, Colo.–(BUSINESS WIRE)–Arrow Electronics collaborates with Romanian startup .lumen on AI glasses that replicate the key functions of a guide dog on a wearable headset.
National Vision Reaffirms Fiscal 2025 Outlook Ahead of Participation at the ICR Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reaffirmed its fiscal 2025 outlook ahead of its participation at the 2026 ICR Conference. The Company reaffirms its fiscal 2025 outloo…
Astoriom Appoints Will Edwards as Chief Executive Officer
ROCHDALE, United Kingdom–(BUSINESS WIRE)– #Astoriom–Astoriom today announced the appointment of Will Edwards, MBA as CEO to support global scale-up of sample management operations.
Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar’s Eye Care Solutions Designed to Improve Dosing Precision, Including Newest Technology, Beat the Blink™
Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors
BOSTON–(BUSINESS WIRE)– #genetherapy–Diorasis Therapeutics, a Boston-based biotechnology company developing durable gene therapies for glaucoma and other ophthalmic diseases, today announced the appointment of Richard A. Kresch, MD, to its Board of …
Abbelight kondigt een succesvolle Serie B-investering aan, geleid door AVANT BIO, om innovatie in beeldvorming te versnellen en toepassing in een ruimer klantenbestand op schaal te brengen
PARIJS–(BUSINESS WIRE)–Abbelight, een wereldleider en pionier in end-to-end oplossingen voor super-resolutiemicroscopie, kondigde vandaag een succesvolle Serie B-financieringsronde aan, geleid door AVANT BIO, een verstrekker van groeikapitaal die zic…
Abbelight kündigt erfolgreiche Serie-B-Finanzierungsrunde unter Federführung von AVANT BIO an, um Innovationen im Bereich Bildgebung voranzutreiben und deren Verbreitung bei einem größeren Kundenstamm zu fördern
PARIS–(BUSINESS WIRE)–Abbelight, ein Weltmarktführer und Pionier im Bereich End-to-End-Lösungen für die Superauflösungsmikroskopie, gab heute den erfolgreichen Abschluss einer Serie-B-Finanzierungsrunde unter der Leitung von AVANT BIO bekannt, einer …
Abbelight annuncia il successo dell'investimento di serie B guidato da AVANT BIO per accelerare l'innovazione dell'imaging e incrementare l'adozione da parte di un'ampia clientela
PARIGI–(BUSINESS WIRE)–Abbelight, un leader globale e un pioniere nelle soluzioni complete di microscopia a super risoluzione, oggi ha annunciato il successo di un round di finanziamento di serie B guidato da AVANT BIO, società di capitali di crescit…